US

H.R. 5853 the Gray Market Drug Reform and Transparency Act

Summary Read full text

To prohibit wholesalers from purchasing prescription drugs from pharmacies, and to enhance information and transparency regarding drug wholesalers engaged in interstate commerce. Read more

Sentiment Map

National Constituent Input

0%

0%

0 total users

State Input

0%

0%

No input from this state

District Input

0%

0%

No input from this district

Activity Feed

Filter

  • {{ cardCount('all') }} All Activity
  • {{ cardCount('Bill') }} Bill Activity
  • {{ cardCount('Congress') }} Lawmaker Activity
  • {{ cardCount('Org') }} Stakeholder Activity
  • {{ cardCount('User') }} Constituent Activity

Stakeholder Positions (0)